¿Qué es la MENINGITIS MENINGOCÓCICA? 

Todos los niños y niñas deberían estar protegidos contra la meningitis meningocócica. 2

La meningitis meningocócica es un tipo de meningitis provocada por la bacteria Neisseria meningitidis.2 Es una infección grave que puede causar daño cerebral grave y hasta la muerte incluso cuando ya se está en tratamiento.2

Contagiarse de MENINGITIS puede ser así de fácil 1

Se puede transmitir a través de la saliva y, si no se trata, podría causar la muerte en solo 24 horas. 2

Preservar la salud y el bienestar de cada miembro de la familia es la máxima prioridad. Algo que necesita tener en cuenta es la meningitis meningocócica, una enfermedad grave que puede afectar a su familia y amigos, y poner en riesgo su salud en cuestión de horas. 2

Siempre queremos proteger lo que es más importante para nosotros. Proteja a su familia contra la meningitis meningocócica.

¿Quiénes están en riesgo?

  • Bebés y niños de cuatro años y menores (referencia14, 16)
  • Adolescentes y adultos (entre 15 y 24 años)(referencia 14, 16)
  • Viajeros(referencia 12)
  • Adultos mayores y personas con sistema inmune debilitado (Referencia 18)

Programe su vacunación

CONSULTE QUE TIPO DE VACUNA SE PUEDE APLICAR

1. Canadian Pediatric Society. Meningococcal Vaccine. Paediatr Child Health 2005;10(2); 2. World Health Organization. Meningococcal meningitis. Available from https://ww- w.who.int/news-room/fact-sheets/detail/meningococcal-meningitis. Accessed 14 December 2020.; 3. For Every Child, Every Right: The Convention on the Rights of the Child at a crossroads. New York: United Nations Children’s Fund (UNICEF), 2019.; 4. Centers for Disease Control and Prevention (CDC). Meningitis: About Bacterial Meningitis Infection, 2019. CDC website. https://www.cdc.gov/meningitis/ bacterial.html. Accessed 14 December 2020;5. Centers for Disease Control and Prevention (CDC). Meningitis: Viral, 2019. CDC website. https://www. cdc.gov/meningitis/viral.html. Accessed 14 December 2020;6.Thompson M, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L et al. Clinical recognition of meningococcal disease in children and adolescents. The Lancet. 2006; 367(9508):397-403; 7. Centers for Disease Control and Prevention (CDC). Meningococcal: Signs and Symptoms, 2017. CDC website. https://www.cdc.gov/meningococcal/ about/symptoms.html. Accessed 14 December 2020; 8. Zunt J, Kassebaum N, Blake N, Glennie L, Wright C, Nichols E et al. Global, regional, and national burden of meningitis, 2016–1990: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2018;. 17(12): 1061-1082; 9. Viner R, Booy R, Johnson H, Edmunds W, Hudson L, Bedford H et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. The Lancet Neurology. 2012; 11(9): 774-783; 10. Bettinger J, Scheifele D, Le Saux N, Halperin S, Vaudry W, Tsang R. The Disease Burden of Invasive Meningococcal Serogroup B Disease in Canada. The Pediatric Infectious Disease Journal. 2013;32(1):e20-e25;11. Centers for Disease Control and Prevention (CDC). Meningococcal: Causes and Transmission, 2019. CDC website. https://www.cdc.gov/ meningococcal/about/causes- transmission. html. Accessed 14 December 2020.;
12. World Health Organization. Weekly Epidemiological Record. 2011; 86: 521-540; 13. Meningitis Research Foundation of Canada. Meningococcal Disease in Child Care Settings. Available at: https://meningitis.ca/en/MenDiseaseChildCare. Accessed 14 December 2020. 14. Centers for Disease Control and Prevention (CDC). Meningococcal:Surveillance, 2019. CDC website. https://www.cdc.gov/ meningococcal/ surveillance/index.html. Accessed 14 December 2020; 15. Public Health England. Invasive meningococcal disease in England:annual laboratory confirmed reports for epidemiological year 2017 to 2018. Health Protection Report, 2018. Publishing service website. https://assets. publishing.ser- vice.gov.uk/government/uploads/ system/uploads/attachment_data /file/751821/hpr3818_IMD.pdf. Accessed 14 December 2020; 16. European Centre for Disease Prevention
and Control (ECDC). Invasive meningococcal disease: Annual Epidemiological Report for 2017. ECDC website. https://www.ecdc.europa.eu/sites/default/files/documents/ AER_for_2017-invasive-meningococcal-disease.pdf. Accessed 14 December 2020; 17. Judelsohn R, Marshall G. The Burden of Infant Meningococcal Disease in the United States. Journal of the Pediatric Infectious Diseases Society 2012;1(1):64–73.; 18. Choi C. Bacterial Meningitis in Aging Adults. Clinical Infectious Diseases. Clinical Infectious Diseases. 2001;33(8) 1380-1385. 19. Purmohamad, A, Abasi E, Azimi T et al. Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: A systematic review and meta-analysis.Microb Pathog 2019 134:103571